EDAP TMS SA to Announce Third Quarter and Nine Months 2019 Financial Results on Wednesday, November 13, 2019
EDAP TMS SA to Announce Third Quarter and Nine Months 2019 Financial Results on Wednesday, November 13, 2019
Company to host conference call and webcast on
An accompanying conference call and webcast will be conducted by Philippe Chauveau, Chairman of the Board, Marc Oczachowski, Chief Executive Officer; and François Dietsch, Chief Financial Officer, to review the results. The call will be held at 8:30am EDT on Thursday, November 14, 2019. Please refer to the information below for conference call dial-in information and webcast registration.
Conference Call & Webcast
Domestic: 877-451-6152
International: 201-389-0879
Passcode: 13695746
Webcast: http://public.viavid.com/index.php?id=136640
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market for almost 40 years, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems. For more information on the Company, please visit http://www.edap-tms.com, and us.hifu-prostate.com.
CONTACTS:
Investor Relations / Legal Affairs
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
212-915-2568
jeremy@lifesciadvisors.com
Source: EDAP TMS S.A.